{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01323",
      "entity_text" : "IIR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01325",
      "entity_text" : "t-BHQ",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Furthermore, treatment with t-BHQ, an activator of Nrf2, was observed to attenuate IIR induced tissue injury, mitigate intestinal barrier dysfunction, reduce proinflammatory cytokines and apoptotic factors, and inhibit IkappaB kinase / IkappaB phosphorylation and NF-kappaB nuclear translocation.",
  "reading_complete" : "2020-08-03T13:15:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:14:30Z",
  "trigger" : "attenuate",
  "evidence" : [ "t-BHQ, an activator of Nrf2, was observed to attenuate IIR" ],
  "pmc_id" : "5716448",
  "score" : 0
}